1. Home
  2. CVAC vs SA Comparison

CVAC vs SA Comparison

Compare CVAC & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • SA
  • Stock Information
  • Founded
  • CVAC 2000
  • SA 1979
  • Country
  • CVAC Germany
  • SA Canada
  • Employees
  • CVAC N/A
  • SA N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • SA Precious Metals
  • Sector
  • CVAC Health Care
  • SA Basic Materials
  • Exchange
  • CVAC Nasdaq
  • SA Nasdaq
  • Market Cap
  • CVAC 1.2B
  • SA 1.5B
  • IPO Year
  • CVAC 2020
  • SA N/A
  • Fundamental
  • Price
  • CVAC $5.41
  • SA $15.73
  • Analyst Decision
  • CVAC Hold
  • SA
  • Analyst Count
  • CVAC 3
  • SA 0
  • Target Price
  • CVAC $6.83
  • SA N/A
  • AVG Volume (30 Days)
  • CVAC 974.1K
  • SA 634.8K
  • Earning Date
  • CVAC 08-14-2025
  • SA 08-12-2025
  • Dividend Yield
  • CVAC N/A
  • SA N/A
  • EPS Growth
  • CVAC N/A
  • SA N/A
  • EPS
  • CVAC 0.87
  • SA N/A
  • Revenue
  • CVAC $566,039,775.00
  • SA N/A
  • Revenue This Year
  • CVAC N/A
  • SA N/A
  • Revenue Next Year
  • CVAC $24.04
  • SA N/A
  • P/E Ratio
  • CVAC $6.24
  • SA N/A
  • Revenue Growth
  • CVAC 787.60
  • SA N/A
  • 52 Week Low
  • CVAC $2.37
  • SA $9.40
  • 52 Week High
  • CVAC $5.72
  • SA $20.55
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 59.79
  • SA 65.85
  • Support Level
  • CVAC $5.42
  • SA $15.26
  • Resistance Level
  • CVAC $5.49
  • SA $16.05
  • Average True Range (ATR)
  • CVAC 0.07
  • SA 0.49
  • MACD
  • CVAC -0.06
  • SA 0.01
  • Stochastic Oscillator
  • CVAC 36.67
  • SA 85.38

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

Share on Social Networks: